Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, ...
Transgenic ferret models ratted out how a rare cell type affects airway function. To determine whether these CFTR-rich cells are the lung’s airway traffic controllers, Engelhardt’s team developed ...
Please provide your email address to receive an email when new articles are posted on . Combination therapy with lumacaftor/ivacaftor was safe and well tolerated for up to 120 weeks in children aged 6 ...
Modulator therapy does not appear to affect the magnitude of lung function impairment or recovery pattern during pulmonary ...
Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...
Please provide your email address to receive an email when new articles are posted on . Researchers deemed 24-week vanzacaftor/tezacaftor/deutivacaftor safe in 6- to ...
We have prioritized the assessment of Kaftrio and Kalydeco for this age range in view of the unmet needs of children with cystic fibrosis. As with all products, we will keep the safety of Kaftrio and ...
PHILADELPHIA (CBS) -- A special delivery to Children's Hospital of Philadelphia from a former patient. She said thanks to all the help and support she received at CHOP, and then she went on to become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results